Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Hirotoshi Ukita"'
Autor:
Kazuyo Nakamura, Michihiro Kaya, Yuki Yanagisawa, Keisuke Yamamoto, Nana Takayashiki, Hirotoshi Ukita, Mariko Nagura, Kaori Sugiue, Mariko Kitajima, Kumi Hirano, Hiroki Ishida, Chiharu Onoda, Yutaka Kobayashi, Eiji Nakatani, Keiichi Odagiri, Takaya Suzuki
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Bone metastases are frequently observed in advanced cancer, and bone modifying agents are used to prevent or treat skeletal-related events. Zoledronic acid is contraindicated in patients with severe renal impairment (Ccr
Externí odkaz:
https://doaj.org/article/68653e29483f4025a3d904e57c4852f2
Autor:
Michihiro Kaya, Kazuyo Nakamura, Kyohei Sugiyama, Ayumi Kinae, Hiromi Yamaguchi, Hirotoshi Ukita, Keiichi Odagiri, Chika Ujiie, Jun Kato, Fujito Kageyama, Mariko Nagura, Kumi Matsushita, Kaori Sugiue, Hiroki Ishida, Shinya Endo, Takaya Suzuki
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 47:940-947
In Japan, ledipasvir/sofosbuvir, elbasvir/grazoprevir and glecaprevir/pibrentasvir are recommended as first-line treatments for patients with untreated hepatitis C virus genotype 1. Although they have demonstrated a high efficacy in clinical trials,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd28a471b5586b323dbb79e11663b45e
https://doi.org/10.1111/jcpt.13624
https://doi.org/10.1111/jcpt.13624